This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Avatar Medical, Calder Biosciences Inc.. Active years: 2016-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2021
Title: The Innovations of Mark Andrew Yondola
Introduction
Mark Andrew Yondola is an accomplished inventor based in Medford, NY (US). He holds two patents that showcase his contributions to the field of biotechnology, particularly in the development of influenza hemagglutinin proteins.
Latest Patents
Yondola's latest patents focus on influenza hemagglutinin ('HA') polypeptides, proteins, and protein complexes. These innovations are engineered to maintain their native trimeric conformation, even when the head domain of the HA protein is removed or disrupted. The patents also describe compositions that include these polypeptides and methods for their use, particularly as vaccine immunogens.
Career Highlights
Throughout his career, Yondola has worked with notable companies such as Avatar Medical and Calder Biosciences Inc. His work in these organizations has contributed significantly to advancements in medical technology and vaccine development.
Collaborations
Yondola has collaborated with professionals like Christopher P. Marshall and Peter Joseph Alff, enhancing the impact of his innovations through teamwork and shared expertise.
Conclusion
Mark Andrew Yondola's contributions to the field of biotechnology, particularly through his patents on influenza hemagglutinin proteins, highlight his role as a significant inventor in the industry. His work continues to influence vaccine development and medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile